Mainolfi Nello
Insider CIK 1821189 · KYMR President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-10-01 | 2026-10-01 | 30,000 | — | $0 | 60,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-01 | 262 | $116.12 | $30.4K | 666,568 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-01 | 8,230 | $115.40 | $949.7K | 666,830 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-01 | 7,601 | $114.43 | $869.8K | 675,060 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-01 | 4,876 | $113.24 | $552.2K | 682,661 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-01 | 5,506 | $112.42 | $619.0K | 687,537 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-10-01 | 2026-10-01 | 3,525 | $111.44 | $392.8K | 693,043 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-10-01 | 2026-10-01 | 30,000 | $2.08 | $62.4K | 696,568 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-07-07 | 2026-07-07 | 45,559 | — | $0 | 90,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-07-07 | 2026-07-07 | 4,441 | — | $0 | 14,284 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-07-07 | 2026-07-07 | 50,000 | $119.00 | $5.95M | 666,568 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-07-07 | 2026-07-07 | 50,000 | $2.08 | $104.0K | 716,568 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-07-01 | 2026-07-02 | 80,000 | — | $0 | 135,559 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-02 | 3,336 | $116.56 | $388.8K | 666,568 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-02 | 24,105 | $114.96 | $2.77M | 713,954 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-02 | 44,050 | $115.69 | $5.10M | 669,904 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-02 | 6,626 | $113.98 | $755.2K | 738,059 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-02 | 1,883 | $112.80 | $212.4K | 744,685 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-07-01 | 2026-07-02 | 80,000 | $2.08 | $166.4K | 746,568 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-04-29 | 2026-04-29 | 30,000 | — | $0 | 215,559 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-29 | 2026-04-29 | 12,059 | $81.70 | $985.2K | 667,131 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-29 | 2026-04-29 | 17,005 | $80.74 | $1.37M | 679,190 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-04-29 | 2026-04-29 | 936 | $82.45 | $77.2K | 666,195 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-04-29 | 2026-04-29 | 30,000 | $2.08 | $62.4K | 696,195 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2026-03-02 | 2026-03-04 | 215,000 | — | $0 | 215,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-02-25 | 2026-02-25 | 30,000 | — | $0 | 245,559 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-02-25 | 2026-02-25 | 5,434 | $90.39 | $491.2K | 670,997 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-02-25 | 2026-02-25 | 30,000 | $2.08 | $62.4K | 696,195 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-02-25 | 2026-02-25 | 19,764 | $89.78 | $1.77M | 676,431 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-02-25 | 2026-02-25 | 3,293 | $91.76 | $302.2K | 667,704 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-02-25 | 2026-02-25 | 1,501 | $92.81 | $139.3K | 666,203 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-02-25 | 2026-02-25 | 8 | $93.49 | $748 | 666,195 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-01-05 | 2026-01-06 | 3,118 | — | $0 | 446,882 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-01-05 | 2026-01-06 | 3,118 | $32.07 | $100.0K | 666,195 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-12-31 | 2025-12-31 | 30,000 | — | $0 | 275,559 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-31 | 2025-12-31 | 23,986 | $77.95 | $1.87M | 669,091 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-31 | 2025-12-31 | 6,014 | $78.52 | $472.2K | 663,077 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-12-31 | 2025-12-31 | 30,000 | $2.08 | $62.4K | 693,077 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-12-17 | 2025-12-17 | 2,595 | — | $0 | 272,505 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-12-17 | 2025-12-17 | 2,595 | $38.53 | $100.0K | 663,077 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-12-08 | 2025-12-08 | 100,000 | — | $0 | 305,559 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-12-08 | 2025-12-08 | 100,000 | $89.17 | $8.92M | 660,482 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-12-08 | 2025-12-08 | 100,000 | $2.08 | $208.0K | 760,482 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-10-29 | 2025-10-29 | 30,000 | — | $0 | 405,559 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-10-29 | 2025-10-29 | 24,511 | $61.02 | $1.50M | 664,109 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-10-29 | 2025-10-29 | 1,862 | $59.72 | $111.2K | 688,620 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-10-29 | 2025-10-29 | 3,627 | $61.46 | $222.9K | 660,482 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-10-29 | 2025-10-29 | 30,000 | $2.08 | $62.4K | 690,482 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-09-16 | 2025-09-16 | 30,000 | — | $0 | 435,559 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-09-16 | 2025-09-16 | 30,000 | $2.08 | $62.4K | 690,482 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-09-16 | 2025-09-16 | 30,000 | $49.00 | $1.47M | 660,482 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-06-03 | 2025-06-03 | 30,000 | — | $0 | 465,559 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-06-03 | 2025-06-03 | 30,000 | $49.00 | $1.47M | 660,482 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-06-03 | 2025-06-03 | 30,000 | $2.08 | $62.4K | 690,482 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2025-03-03 | 2025-03-03 | 365,000 | — | $0 | 365,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-01-10 | 2025-01-13 | 10,000 | — | $0 | 495,559 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-01-10 | 2025-01-13 | 10,000 | $2.08 | $20.8K | 659,959 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-07-01 | 2024-07-01 | 18,773 | — | $0 | 288,456 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-07-01 | 2024-07-01 | 18,773 | $5.33 | $100.1K | 649,959 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-06-18 | 2024-06-20 | 14,413 | — | $0 | 505,559 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-06-18 | 2024-06-20 | 14,413 | $2.08 | $30.0K | 631,186 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-03-04 | 530,000 | — | $0 | 530,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-01-02 | 2024-01-02 | 9,000 | — | $0 | 519,972 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-01-02 | 2024-01-02 | 9,000 | $2.08 | $18.7K | 615,570 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2023-11-03 | 2023-11-06 | 17,632 | — | $0 | 528,972 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2023-11-03 | 2023-11-06 | 2,368 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2023-11-03 | 2023-11-06 | 17,632 | $2.08 | $36.7K | 606,570 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2023-11-03 | 2023-11-06 | 2,368 | $2.08 | $4.9K | 588,938 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2023-08-08 | 2023-08-08 | 12,000 | — | $0 | 2,368 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2023-08-08 | 2023-08-08 | 12,000 | $2.08 | $25.0K | 586,570 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 450,000 | — | $0 | 450,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-12-08 | 2022-12-08 | 10,000 | — | $0 | 18,725 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-12-08 | 2022-12-08 | 10,000 | $2.08 | $20.8K | 573,700 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-10-17 | 2022-10-17 | 27,676 | — | $0 | 546,604 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-10-17 | 2022-10-17 | 32,056 | — | $0 | 14,368 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-10-17 | 2022-10-17 | 27,676 | $2.08 | $57.6K | 561,931 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-10-17 | 2022-10-17 | 32,056 | $2.08 | $66.7K | 534,255 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-05-03 | 2022-05-03 | 20,000 | — | $0 | 46,424 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-05-03 | 2022-05-03 | 20,000 | $2.08 | $41.6K | 502,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 275,100 | — | $0 | 275,100 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-01-14 | 2022-01-14 | 10,000 | — | $0 | 66,424 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-01-14 | 2022-01-14 | 10,000 | $2.08 | $20.8K | 482,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-01-12 | 2022-01-12 | 8,612 | — | $0 | 574,280 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-01-12 | 2022-01-12 | 8,612 | $2.08 | $17.9K | 480,811 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-01-12 | 2022-01-12 | 2,726 | $51.31 | $139.9K | 478,085 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-01-12 | 2022-01-12 | 4,022 | $52.02 | $209.2K | 474,063 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-01-12 | 2022-01-12 | 1,623 | $53.27 | $86.5K | 472,440 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-01-12 | 2022-01-12 | 241 | $53.97 | $13.0K | 472,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-01-11 | 2022-01-12 | 16,923 | — | $0 | 582,892 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-01-11 | 2022-01-12 | 347 | $55.05 | $19.1K | 472,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-01-11 | 2022-01-12 | 6,644 | $54.42 | $361.6K | 472,546 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-01-11 | 2022-01-12 | 9,932 | $53.68 | $533.1K | 479,190 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-01-11 | 2022-01-12 | 16,923 | $2.08 | $35.2K | 489,122 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-01-10 | 2022-01-12 | 22,465 | — | $0 | 599,815 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-01-10 | 2022-01-12 | 7,485 | $52.46 | $392.7K | 487,179 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-01-10 | 2022-01-12 | 10,673 | $53.35 | $569.4K | 476,506 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-01-10 | 2022-01-12 | 4,201 | $54.40 | $228.5K | 472,305 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-01-10 | 2022-01-12 | 106 | $54.99 | $5.8K | 472,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-01-10 | 2022-01-12 | 22,465 | $2.08 | $46.7K | 494,664 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-12-16 | 2021-12-16 | 8,000 | — | $0 | 76,424 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-12-16 | 2021-12-16 | 8,000 | $2.08 | $16.6K | 472,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-10-11 | 2021-10-12 | 6,456 | — | $0 | 28,725 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-10-11 | 2021-10-12 | 744 | $54.50 | $40.5K | 464,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-10-11 | 2021-10-12 | 5,712 | $53.58 | $306.0K | 464,943 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-10-11 | 2021-10-12 | 6,456 | $2.08 | $13.4K | 470,655 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-10-08 | 2021-10-12 | 41,544 | — | $0 | 35,181 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-10-08 | 2021-10-12 | 9,369 | $56.82 | $532.3K | 475,138 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-10-08 | 2021-10-12 | 41,544 | $2.08 | $86.4K | 505,743 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-10-08 | 2021-10-12 | 21,236 | $55.56 | $1.18M | 484,507 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-10-08 | 2021-10-12 | 2,078 | $57.29 | $119.0K | 473,060 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-10-08 | 2021-10-12 | 271 | $61.87 | $16.8K | 464,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-10-08 | 2021-10-12 | 670 | $60.32 | $40.4K | 464,470 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-10-08 | 2021-10-12 | 7,920 | $59.28 | $469.5K | 465,140 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-08-19 | 2021-08-19 | 12,000 | — | $0 | 84,424 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-08-19 | 2021-08-19 | 12,000 | $2.08 | $25.0K | 464,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-08-04 | 2021-08-05 | 1,037 | — | $0 | 76,725 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-08-04 | 2021-08-05 | 1,037 | $2.08 | $2.2K | 453,236 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-08-04 | 2021-08-05 | 1,037 | $60.03 | $62.3K | 452,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-08-03 | 2021-08-05 | 5,669 | — | $0 | 77,762 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-08-03 | 2021-08-05 | 5,669 | $60.07 | $340.5K | 452,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-08-03 | 2021-08-05 | 5,669 | $2.08 | $11.8K | 457,868 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-08-02 | 2021-08-02 | 23,456 | — | $0 | 83,431 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-08-02 | 2021-08-02 | 23,456 | $2.08 | $48.8K | 475,655 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-08-02 | 2021-08-02 | 300 | $62.21 | $18.7K | 452,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-08-02 | 2021-08-02 | 21,632 | $60.21 | $1.30M | 454,023 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-08-02 | 2021-08-02 | 1,524 | $61.28 | $93.4K | 452,499 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-07-30 | 2021-08-02 | 6,279 | — | $0 | 106,887 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-07-30 | 2021-08-02 | 6,279 | $2.08 | $13.1K | 458,478 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-07-30 | 2021-08-02 | 6,279 | $60.07 | $377.2K | 452,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-07-29 | 2021-08-02 | 680 | — | $0 | 113,166 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-07-29 | 2021-08-02 | 680 | $2.08 | $1.4K | 452,879 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-07-29 | 2021-08-02 | 680 | $60.00 | $40.8K | 452,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-07-28 | 2021-07-28 | 3,864 | — | $0 | 113,846 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-07-28 | 2021-07-28 | 3,864 | $2.08 | $8.0K | 456,063 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-07-28 | 2021-07-28 | 3,864 | $60.15 | $232.4K | 452,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-07-26 | 2021-07-28 | 9,015 | — | $0 | 117,710 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-07-26 | 2021-07-28 | 9,015 | $60.15 | $542.3K | 452,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-07-26 | 2021-07-28 | 9,015 | $2.08 | $18.8K | 461,214 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-07-08 | 2021-07-09 | 48,000 | — | $0 | 126,725 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-07-08 | 2021-07-09 | 48,000 | $2.08 | $99.8K | 500,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-07-08 | 2021-07-09 | 595 | $51.64 | $30.7K | 452,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-07-08 | 2021-07-09 | 6,372 | $50.96 | $324.7K | 452,794 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-07-08 | 2021-07-09 | 23,803 | $49.71 | $1.18M | 459,166 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-07-08 | 2021-07-09 | 17,230 | $49.15 | $846.9K | 482,969 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-06-14 | 2021-06-14 | 40,000 | — | $0 | 96,424 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-06-14 | 2021-06-14 | 40,000 | $2.08 | $83.2K | 452,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-06-10 | 2021-06-11 | 23,009 | — | $0 | 174,725 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-06-10 | 2021-06-11 | 6,912 | $51.46 | $355.7K | 418,193 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-06-10 | 2021-06-11 | 10,103 | $50.63 | $511.5K | 425,105 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-06-10 | 2021-06-11 | 23,009 | $2.08 | $47.9K | 435,208 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-06-10 | 2021-06-11 | 5,994 | $52.53 | $314.9K | 412,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-06-09 | 2021-06-09 | 5,752 | — | $0 | 197,734 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-06-09 | 2021-06-09 | 5,752 | $2.08 | $12.0K | 417,951 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-06-09 | 2021-06-09 | 5,752 | $50.02 | $287.7K | 412,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-06-08 | 2021-06-09 | 270 | — | $0 | 203,486 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-06-08 | 2021-06-09 | 270 | $50.00 | $13.5K | 412,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-06-08 | 2021-06-09 | 270 | $2.08 | $562 | 412,469 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-06-07 | 2021-06-09 | 12,724 | — | $0 | 203,756 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-06-07 | 2021-06-09 | 12,724 | $2.08 | $26.5K | 424,923 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-06-07 | 2021-06-09 | 12,724 | $50.14 | $638.0K | 412,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-05-19 | 2021-05-19 | 15,000 | — | $0 | 136,424 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-05-19 | 2021-05-19 | 15,000 | $2.08 | $31.2K | 412,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-05-12 | 2021-05-14 | 8,245 | — | $0 | 216,480 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-05-12 | 2021-05-14 | 8,245 | $50.05 | $412.7K | 397,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-05-12 | 2021-05-14 | 8,245 | $2.08 | $17.1K | 405,444 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-04-26 | 2021-04-26 | 2,768 | — | $0 | 224,725 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-04-26 | 2021-04-26 | 2,768 | $2.08 | $5.8K | 399,967 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-04-26 | 2021-04-26 | 2,768 | $40.18 | $111.2K | 397,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-04-23 | 2021-04-26 | 680 | — | $0 | 227,493 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-04-23 | 2021-04-26 | 680 | $40.01 | $27.2K | 397,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-04-23 | 2021-04-26 | 680 | $2.08 | $1.4K | 397,879 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-04-22 | 2021-04-26 | 10,959 | — | $0 | 228,173 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-04-22 | 2021-04-26 | 10,959 | $2.08 | $22.8K | 408,158 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-04-22 | 2021-04-26 | 10,959 | $40.26 | $441.2K | 397,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-04-19 | 2021-04-19 | 653 | — | $0 | 239,132 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-04-19 | 2021-04-19 | 6,000 | — | $0 | 151,424 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-04-19 | 2021-04-19 | 6,000 | $2.08 | $12.5K | 397,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-04-19 | 2021-04-19 | 653 | $40.00 | $26.1K | 391,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-04-19 | 2021-04-19 | 653 | $2.08 | $1.4K | 391,852 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-04-15 | 2021-04-19 | 4,940 | — | $0 | 239,785 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-04-15 | 2021-04-19 | 4,940 | $2.08 | $10.3K | 396,139 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-04-15 | 2021-04-19 | 4,940 | $40.29 | $199.0K | 391,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-04-13 | 2021-04-13 | 15,000 | — | $0 | 157,424 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-04-13 | 2021-04-13 | 15,000 | $2.08 | $31.2K | 391,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-04-12 | 2021-04-12 | 15,267 | — | $0 | 244,725 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-04-12 | 2021-04-12 | 15,267 | $2.08 | $31.8K | 391,466 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-12 | 4,905 | $33.32 | $163.4K | 376,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-12 | 10,362 | $32.29 | $334.6K | 381,104 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-04-09 | 2021-04-12 | 22,794 | — | $0 | 259,992 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-04-09 | 2021-04-12 | 22,794 | $2.08 | $47.4K | 398,993 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-04-09 | 2021-04-12 | 19,052 | $33.58 | $639.8K | 379,941 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-04-09 | 2021-04-12 | 3,742 | $34.19 | $127.9K | 376,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-04-08 | 2021-04-12 | 9,939 | — | $0 | 282,786 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-04-08 | 2021-04-12 | 9,939 | $2.08 | $20.7K | 386,138 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-04-08 | 2021-04-12 | 7,616 | $34.81 | $265.1K | 378,522 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-04-08 | 2021-04-12 | 2,323 | $35.62 | $82.7K | 376,199 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 375,000 | — | $0 | 375,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2020-08-20 | 2020-08-21 | 125,399 | — | $0 | 125,399 | SEC↗ |